Aptose Biosciences appoints Caroline Loewy to its Board of Directors

– CANADA, Mississauga – Aptose Biosciences Inc. (NASDAQ:APTO / TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today announced the appointment of Caroline M.